2020. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s95. DOI:https://doi.org/10.25251/skin.4.supp.95.